Pharma giant Jazz dismisses final patent claim involving cannabinoid epilepsy drug
Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.
News February 11Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.
News February 11Two Republican U.S. senators have introduced a bill that would continue to ban federal tax deductions for the…
News February 10A hemp merchant is suing Tennessee police for $850,000, claiming that authorities allowed hundreds of pounds of federally…
News February 7More than 85% of regulated marijuana products sold in Colorado’s adult-use market might violate health and labeling laws,…
News February 3A federal grand jury has indicted three men for allegedly running a massive illegal cannabis operation involving Chinese…
News January 31For the second time in five months, Michigan regulators are levying serious charges against cannabis processor Sky Labs…
News January 24A new marijuana trade group in California representing the state’s largest retailers aims to improve legislative policies for the…
News January 23A federal appeals court has upheld a Virginia ban on intoxicating hemp products with any THC concentration above…
News January 21A new study on hemp microorganisms could ultimately help researchers, scientists and growers boost production of CBD and…
News January 17Product and food delivery app DoorDash is the latest major company to enter the hemp market.
News January 14